Zymeworks Long Term Deferred Assets (Quarterly) Insights

Zymeworks, Inc. (ZYME)

23.47 -0.16 (-0.68%) USD | NASDAQ | Jan 16, 16:00

23.50 +0.02 (+0.11%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for ZYME.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Jazz Pharmaceuticals Plc	Upgrade
Johnson & Johnson	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Vertex Pharmaceuticals, Inc.	Upgrade
CorMedix, Inc.	--